Joseph Jankowski
Physician Assistant · Newberry, MINPI 1700900578
Payments from drug & device makers
Across 93 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$487
- Lilly USA, LLC$177
- Novo Nordisk$153
- Boehringer Ingelheim$152
- Bayer$109
- Amgen$101
- plus $402 from 12 others
What the payments were for
- Food & beverage$1,580100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $487 |
| Lilly USA, LLC | 12 | $177 |
| Novo Nordisk | 10 | $153 |
| Boehringer Ingelheim | 7 | $152 |
| Bayer | 6 | $109 |
| Amgen | 6 | $101 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $79 |
| GSK | 3 | $56 |
| Indivior Inc. | 2 | $42 |
| Pfizer | 3 | $40 |
| Dexcom, Inc. | 2 | $38 |
| AstraZeneca | 3 | $36 |
| Corcept Therapeutics | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Merck | 1 | $14 |
How this compares
$1,580 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 13 | $93,336 |
| VraylarCariprazine Hcl | 32 | $44,068 |
| EliquisApixaban | 45 | $39,620 |
| JardianceEmpagliflozin | 23 | $22,883 |
| JanuviaSitagliptin Phosphate | 24 | $20,046 |
| OzempicSemaglutide | 17 | $15,999 |
| RybelsusSemaglutide | 14 | $14,126 |
| MounjaroTirzepatide | 11 | $11,371 |
| XareltoRivaroxaban | 12 | $8,564 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $7,549 |
| EntrestoSacubitril/Valsartan | 11 | $6,646 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,037 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 19 | $4,360 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 100 | $3,279 |
| Ventolin HfaAlbuterol Sulfate | 44 | $2,450 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $487 | $44,06832 claims |
| PfizerEliquis | $40 | $39,62045 claims |
| Novo NordiskOzempic, Rybelsus | $153 | $30,12531 claims |
| Boehringer IngelheimJardiance | $152 | $22,88323 claims |
| MerckJanuvia | $14 | $20,04624 claims |
| Lilly USA, LLCMounjaro | $177 | $11,37111 claims |
| GSKBreo Ellipta | $56 | $5,03713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Newberry
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.